Jamie Smith
Media Relations
Email: jamie.smith@molnlycke.com
Phone: +46 722-553573
Mölnlycke donates patent to spark innovation in sustainable healthcare
Gothenburg, Sweden. 12 November 2025. Mölnlycke Health Care, a global leader in MedTech, is the first company to donate a patent to SKF’s groundbreaking digital platform, The Patent Bay – taking bold action to harness collaboration and accelerate innovation in sustainable healthcare.
“We are proud to be part of this pioneering initiative,” says Zlatko Rihter, CEO of Mölnlycke Health Care. “Our purpose is to revolutionise care for people and planet. Supporting The Patent Bay is a powerful way to help turn that purpose into action.”
Today’s healthcare systems are under immense pressure to deliver the right care to the right patients, often with fewer resources. Mölnlycke believes that embracing partnerships, collaboration and openness are key to overcoming these challenges. By contributing to The Patent Bay, Mölnlycke is helping unlock new opportunities to help shape more sustainable healthcare systems for the future.
Mölnlycke is sharing a patent family relating to a method to determine a patient’s risk score. The innovation uses patient data to help caregivers predict risks and tailor treatments more effectively. By comparing a patient’s health profile to large-scale models, the patented method may improve treatment accuracy, reduce unnecessary interventions and lower healthcare costs.
Mölnlycke is making its patent freely accessible to innovators, entrepreneurs, researchers and healthcare providers worldwide, with the ultimate aim to improve patient outcomes.
“The Patent Bay was founded to accelerate progress through open knowledge and shared innovation. Mölnlycke Health Care’s decision to share smarter patient risk scoring highlights the power of collaboration—enabling better care and advancing healthcare for all. It’s a clear reminder that sharing drives meaningful progress for people, society and the planet,” says Annika Ölme, CTO and Senior Vice President, Technology Development at SKF.
Zlatko Rihter adds, “We encourage other organisations to join us in contributing to The Patent Bay to help drive open innovation for a more sustainable future.”
For more information please contact:
Note to editors
About The Patent Bay
The Patent Bay is a unique platform for sharing patents related to sustainable development, free of charge. It aims to accelerate technologies with the potential to advance sustainability through openness and collaboration. By taking a new approach to industrial innovation and rethinking how it is shared, it removes traditional barriers around patents – making sustainable technologies freely accessible, without the complex licensing or governance structures that often slow collaboration. The initiative reflects a shift from ownership to openness, and represents a practical, collaborative approach to industrial responsibility in the climate era. thepatentbay.com
Latest news
-
Mölnlycke® celebrates 100 million ProcedurePak® trays - advancing operating room efficiency worldwide
Gothenburg, Sweden. 27 January 2026. Mölnlycke Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden, is celebrating the production of 100 million ProcedurePak® trays at the company’s production sites in the Czech Republic.
-
Making sustainable healthcare work
Healthcare systems worldwide are under pressure to deliver more with less. Fewer resources, tighter budgets, and growing demands. In this article, published in Clinical Services Journal, Eric De Kesel, Chief Operating Officer & Executive Vice President Sustainability and Dr Emma Wright, Chief Medical Officer at Mölnlycke Health Care, explain how Mölnlycke is turning sustainable healthcare from aspiration into practice by connecting performance, people, and planet.
-
Clinician wellbeing is key to sustainable healthcare
Clinician wellbeing is the cornerstone of sustainable healthcare. Dr Emma Wright, Chief Medical Officer at Mölnlycke Health Care, explains why supporting those who deliver care is essential and how value-based healthcare can unlock better outcomes for patients, healthcare professionals, and healthcare systems.
-
Mölnlycke recognised with EUPD’s ‘ESG Transparency Award
We are delighted to announce that Mölnlycke was recognised with ‘ESG Transparency Award' by EUPD Research. Mölnlycke achieved the highest excellence level with the total score of 95,5%.
-
Shaping wound care policy across Europe
We are proud to play our part in shaping the future of wound care in Europe. Mölnlycke has been elected one of the organisations leading the Wound Care Sector Working Group at MedTech Europe, the industry association representing medical technology across the continent.
-
2025 Future Summit by Mölnlycke Health Care
Smarter incision care and partnerships are key to enhanced clinical practise and improved patient outcomes.
-
Mölnlycke establishes first wound care manufacturing site in China
Changshu, China, and Gothenburg, Sweden. 5 November 2025. Mölnlycke® Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden, is celebrating the commencement of its new wound care manufacturing site in Changshu, China. This strategic investment marks a milestone in Mölnlycke’s growth journey and the beginning of localised manufacturing in one of the world’s fastest-growing MedTech markets.
-
Mölnlycke Health Care’s global headquarters ranked number one workplace in Sweden and top 20 globally in Leesman workplace experience survey
Gothenburg, Sweden, 15 October 2025 Mölnlycke® Health Care is proud to announce that its global headquarters have placed number one in Sweden, and top 20 globally, in the prestigious Leesman® Index, a benchmark survey measuring workplace experience across thousands of organisations worldwide.
-
Mölnlycke Health Care breaks ground on $135 million expansion of Wound Care manufacturing facility in Brunswick, Maine
Brunswick, Maine, USA and Gothenburg, Sweden. 23 September 2025. Mölnlycke® Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden, today celebrates the groundbreaking of a major expansion to its wound care manufacturing capacity in Brunswick, Maine. This milestone marks the beginning of a $135 million investment aimed at significantly increasing Mölnlycke’s manufacturing capacity in the United States.